Nucleic acid hybridization

In Situ Hybridization (ISH) Market to Grow by USD 475.05 Million During 2021-2025|Technavio

Retrieved on: 
Wednesday, April 28, 2021

b'To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40880\nIn Situ Hybridization (ISH) Market 2021-2025: Vendor Analysis and Scope\nTo help businesses improve their market position, the in situ hybridization (ISH) market provides a detailed analysis of around 25 vendors operating in the market.

Key Points: 
  • b'To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40880\nIn Situ Hybridization (ISH) Market 2021-2025: Vendor Analysis and Scope\nTo help businesses improve their market position, the in situ hybridization (ISH) market provides a detailed analysis of around 25 vendors operating in the market.
  • However, the emergence of alternative techniquesmay threaten the growth of the market.\nBacked with competitive intelligence and benchmarking, our research reports on the in situ hybridization (ISH) market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.\nGlobal Genetic Testing Market-The genetic testing market is segmented byproduct (equipment and consumables), application (predictive and diagnostic testing and pharmacogenomic testing), and geography (North America, Europe, Asia, and ROW).
  • Download FREE Sample Report\nGlobal MRSA Testing Market-The MRSA testing market is segmented byend-user (hospitals and diagnostic laboratories and academic and research institutes), geography (North America, Europe, Asia, and ROW), and key vendors.
  • Download FREE Sample Report\nIn Situ Hybridization (ISH) Market 2021-2025: Key Highlights\n'

Insights on the Cytogenetics Global Market to 2030 - Profiles of 70 Relevant Companies Along with Their 80 Collaborations

Retrieved on: 
Monday, April 26, 2021

Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879.

Key Points: 
  • Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879.
  • The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.
  • Molecular cytogenetics includes the applicationS of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection.
  • Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies.\nFISH remains the single most important technology in cytogenetics.

Global Global Fluorescent in Situ Hybridization (FISH) Probe Market to 2024 by Probe Type, Technology, Application, End-use, & Region

Retrieved on: 
Monday, September 21, 2020

What has been the impact of COVID-19 on the global fluorescence in situ hybridization (FISH) probe market?

Key Points: 
  • What has been the impact of COVID-19 on the global fluorescence in situ hybridization (FISH) probe market?
  • What is the structure of the global fluorescence in situ hybridization (FISH) probe market and who are the key players?
  • Fluorescence in situ hybridization (FISH) refers to a sub-atomic cytogenetic technique that uses fluorescent probes to visualize genetic materials.
  • Looking forward, the report expects the global fluorescence in situ hybridization (FISH) probe market to continue its moderate growth during the next five years.

Global Cytogenetics Companies, Technologies, Markets, 2019-2020 & Estimates for 2024 and 2029

Retrieved on: 
Friday, September 18, 2020

Markets figure are given for the year 2019 and estimates are made for the years 2024 and 2029.

Key Points: 
  • Markets figure are given for the year 2019 and estimates are made for the years 2024 and 2029.
  • The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.
  • Molecular cytogenetics includes the applicationS of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection.
  • Microarray/biochip-based technologies for cytogenetics promise to speed up the detection of chromosome aberrations now examined by FISH.

Fluorescent in Situ Hybridization (FISH) Probe Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2014-2019 & 2020-2024 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 15, 2020

The "Fluorescent in Situ Hybridization (FISH) Probe Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fluorescent in Situ Hybridization (FISH) Probe Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • Looking forward,, the publisher expects the global fluorescence in situ hybridization (FISH) probe market to continue its moderate growth during the next five years.
  • What has been the impact of COVID-19 on the global fluorescence in situ hybridization (FISH) probe market?
  • What is the structure of the global fluorescence in situ hybridization (FISH) probe market and who are the key players?

Global Cytogenetics Technologies, Markets & Companies Report 2020 with Profiles of 70 Companies Along with their 80 Collaborations - ResearchAndMarkets.com

Retrieved on: 
Monday, September 14, 2020

The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.

Key Points: 
  • The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.
  • Molecular cytogenetics includes the applicationS of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection.
  • Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies.
  • The report includes summary profiles of 70 companies relevant to cytogenetics along with their 80 collaborations.

In Situ Hybridization Market by Product, Technology, Application, and End-user, Region - Global Forecast to 2025

Retrieved on: 
Thursday, September 3, 2020

The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.

Key Points: 
  • The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.
  • The increasing incidence of cancer and awareness of companion diagnostics test are the major factors driving the growth of this market.
  • However, the lack of skilled professionals poses a challenge to the ISH market.
  • Based on technology, the ISH market is segmented broadly into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH).

Global In Situ Hybridization Industry to 2025 - Untapped Markets in Developing Countries Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, August 31, 2020

The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.

Key Points: 
  • The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.
  • The increasing incidence of cancer and awareness of companion diagnostics test are the major factors driving the growth of this market.
  • However, the lack of skilled professionals poses a challenge to the ISH market.
  • Based on technology, the ISH market is segmented broadly into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH).

The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4%

Retrieved on: 
Thursday, August 27, 2020

The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.

Key Points: 
  • The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.
  • The increasing incidence of cancer and awareness of companion diagnostics test are the major factors driving the growth of this market.
  • By consumables type, the kits & reagents accounted for the fastest-growing segment of the ISH market.
  • Based on technology, the ISH market is segmented broadly into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH).This segment accounted for the largest share of the global ISH market in 2019.

Bio-Techne Announces Commercial Release Of New Assay For Detecting ASOs, miRNAs, And siRNAs In Tissue

Retrieved on: 
Monday, July 20, 2020

MINNEAPOLIS, July 20, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope platform with the release of the miRNAscope Assay.

Key Points: 
  • MINNEAPOLIS, July 20, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope platform with the release of the miRNAscope Assay.
  • The RNAscope technology is an advanced in situ hybridization assay for the spatial visualization of single-molecule RNA with single-cell resolution directly in intact tissues.
  • The assay addresses a critical need to reliably detect these ultra-short molecules in native tissue with minimal time and effort, delivering data in an easy to interpret format.
  • Kim Kelderman, President of Bio-Techne's Diagnostics and Genomics Segment, commented, "We are excited to expand our in situ RNA tissue analysis leadership position with the release of the miRNAscope Assay.